Contrast-enhanced (CE) MRI was used to monitor breast cancer response to neoadjuvant chemotherapy. Patients underwent CE MRI before and after therapy, together with conventional assessment methods ...

Leach MO, Boggis CR, Dixon AK, Easton DF, Eeles RA, Evans DG, et al; MARIBS study group. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast ...

January 20, 2009 (Rome, Italy) — A new study has shown that the use of a manual thrombectomy device (Export Medtronic; Medtronic) as adjunctive therapy in primary PCI improved procedural outcomes in ...

WINTER SPRINGS, Fla., Dec. 12, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only ...

REHOVOT, Israel--(BUSINESS WIRE)--Clear-Cut Medical announced the CE Marking of its ClearSight™ MRI system for the examination of breast tissue. The ClearSight™ system is a revolutionary compact ...

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval of expanded labelling for its Ellipse™ implantable cardioverter defibrillator (ICD), in addition to ...

St. Jude Medical picked up a CE mark allowing patients implanted with its cardiac resynchronization therapy pacemaker to undergo magnetic resonance imaging. The approval opens up more diagnostic ...

Medical device major Medtronic, Inc. (MDT) recently won CE Mark approval for its Evera MRI SureScan implantable cardioverter-defibrillator (:ICD) System. With the approval, this system has become the ...

New Option in Second-Generation Pacing System Available in Select European Geographies Features Exclusive Technology and Allows Access to Critical Diagnostic Tool MINNEAPOLIS--(BUSINESS WIRE)-- ...

DUBLIN - February 22, 2016 - Medtronic plc (MDT) today announced that it has received CE (Conformité Européenne) Mark for the first and only cardiac resynchronization therapy defibrillators (CRT-Ds) ...